Endocrinology, Hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Ann Endocrinol (Paris). 2010 May;71(3):225-7. doi: 10.1016/j.ando.2010.03.006. Epub 2010 Apr 14.
The treatment of infertility in polycystic ovary syndrome (PCOS) associates lifestyle measures, and the use of drugs to induce ovulation. In this endeavour, clomifene citrate (CC) should be used as the first line of treatment, followed eventually by low dose gonadotrophin stimulation, as a second line. In rare cases, in case of failure of the CC treatment, ovarian drilling i.e. laparoscopic ovarian surgery (LOS), and finally assisted reproduction techniques can be used, if needed. Overall, ovulation induction (representing the CC-gonadotrophin paradigm) is highly effective with a cumulative singleton live birth rate of 72%. The use of insulin sensitizers i.e. metformin in PCOS should be restricted to women with glucose intolerance and/or insulin resistance. Based on recent data available, the routine use of this drug, alone, in ovulation induction is not recommended.
多囊卵巢综合征(PCOS)患者的不孕治疗包括生活方式干预和药物促排卵。氯米芬(CC)是一线治疗药物,若一线治疗失败,可选择小剂量促性腺激素治疗作为二线治疗。极少数情况下,若 CC 治疗失败,可选择卵巢打孔术(腹腔镜卵巢手术,LOS)或辅助生殖技术。总的来说,排卵诱导(即 CC-促性腺激素方案)非常有效,累积活产单胎率为 72%。二甲双胍等胰岛素增敏剂仅适用于存在葡萄糖耐量异常和/或胰岛素抵抗的 PCOS 患者。基于目前的最新数据,不建议将其常规用于排卵诱导。